12
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Outbreaks of histoplasmosis: The spores set sail

      review-article
      *
      PLoS Pathogens
      Public Library of Science

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Human infection with the pathogenic fungus Histoplasma capsulatum produces diverse clinical manifestations, ranging from an influenza-like illness to a cavitary lung disease to life-threatening dissemination affecting multiple major organ systems [1, 2]. Long considered to be an infection endemic to the midwestern and southeastern United States and Central and South America [3, 4], new epidemiological reports indicate that other areas of the world, and the US for that matter, have indigenous cases. There is increasing recognition of histoplasmosis in China, particularly along the Yangtze River [5, 6], and numerous case reports are emerging from India [7]. In the US, the recent description of cases from Montana suggests that H. capsulatum is wider spread than originally considered. Biology and natural history of H. capsulatum This fungus is considered to be dimorphic; it grows both as a mold and a yeast. The phase depends on temperature. At 25 °C, H. capsulatum exists as a mold and generates two types of conidia or spores-macroconidia and microconidia. These forms are asexual ovoid structures produced at the tips of hyphae. The portal of entry is the lung, and microconidia are considered to be the form that reaches the alveoli and terminal bronchioles of the lung because of their small size (2–5 μm). Exposure of the mold phase to 37 °C induces an orderly change in gene expression, driving conversion of spores into yeast cells that are typically 2–4 μm in diameter [8]. It is this morphotype that causes nearly all the pathology associated with histoplasmosis [3]. Since yeast cells are not transmissible from human to human, they do not promulgate transmission of the fungus in outbreaks. The role of bird and bat droppings The habitat of H. capsulatum is soil laden with bird excreta or bat guano. Contact with the fungus usually requires disturbing the soil, thus aerosolizing spores. Droppings from several avian species have been implicated in supporting the growth of the fungus; these include starlings, blackbirds, pigeons, and, less commonly, oilbirds (found in South America) and grackles [9]. It was not until the 1940s that H. capsulatum was recovered from the soil, thus establishing incontrovertibly that infection is acquired from the environment. The fungus was isolated from soil containing chicken excreta surrounding a chicken coop [9]. The organism is usually found within 20 cm of the ground surface. It thrives in acidic soil rich in nitrogen. This compound is more freely accessible in decomposing rather than fresh excreta. In heavily infested soils, the number of H. capsulatum particles has been estimated to reach 105 per gram of soil [10, 11]. Of note, conidia (or spores) have been identified in soil, and this finding documents the presence of this morphotype in nature [12]. Despite numerous attempts to culture the fungus from environmental reservoirs, H. capsulatum has been notoriously difficult to isolate directly from the soil, although occasionally using a mineral oil flotation process has achieved success. Rather, the simplest and perhaps most reliable method is to inoculate mice intraperitoneally with an emulsion of the soil, wait approximately 15 to 30 days, and culture several organs, including liver, spleen, and lungs, for the presence of the fungus [13]. The mouse mounts sufficient host defenses to eradicate the saprophytes found in the soil. Thus, endemic niches are frequently identified by outbreaks in humans or domestic animals, such as dogs, rather than by recovering fungus from environmental sites. What is it about bird excreta or bat guano that fosters the presence of H. capsulatum? To this day, the answer to this question remains elusive. Attempts have been made in the past, but this work has long been neglected. What we do know is that a carbohydrate from chicken excreta, not otherwise identified, produced excellent growth and sporulation of H. capsulatum. Other constituents in excreta that promote growth of the fungus include salts, particularly phosphate, which is enriched in excreta compared to the surrounding soil, and nitrogen. The nitrogenous substances that fuel growth remain unknown, although urea has been suggested but not definitively documented [9, 11]. Histoplasma outbreaks Numerous reports of epidemics or outbreaks of histoplasmosis in the US and Canada have been described over the years, dating back to the late 1930s [14–16]. An outbreak is defined as involving at least two cases. In 1963, 31 cases of histoplasmosis were identified in Montreal along the St. Lawrence river valley. Although no specific source was detected, the authors noted that the city had been in a construction boom during this period. Perhaps the most ironic episode of multiple infections transpired on Earth Day in 1970. A large number of junior high school students and faculty in Delaware, Ohio were infected after clearing a school courtyard that had been a bird roost [17]. The outbreak that developed in Montreal in the 1960s is an exception to the rule that, prior to the 1970s, most outbreaks developed in rural areas, as might be expected for an infection associated with bird or bat excreta. Given that many of these episodes originally were reported in rural areas, the number of individuals infected often has been fewer than 100. Since the 1970s, the setting for epidemics has shifted from rural to urban [14]. With a shift to a more urban exposure, it is not unexpected that the number of infected individuals exceeds that found in rural areas. The extreme examples of urban epidemics are the two in Indianapolis, Indiana that occurred in the late ‘70s and early ‘80s [18–21]. In the first outbreak, more than 100,000 residents of Indianapolis were infected. It was associated with razing an old amusement park and construction of a tennis stadium in the downtown area. The epidemic persisted for one year and likely had windborne spread, as is more often observed with the spread of Coccidioides sp. The second outbreak resulted from construction of a new natatorium on the campus of Indiana University–Purdue University Indianapolis (IUPUI). In total, approximately 200,000 individuals were infected as a consequence of the two outbreaks. Another important element of these two episodes is the detrimental impact H. capsulatum had on the health of Indianapolis residents. Although outbreaks of histoplasmosis typically do not cause a high degree of mortality or morbidity and much of the disease is self-limited, these two were accompanied by more than 300 hospitalizations and at least 15 deaths. There were more than 40 cases of disseminated histoplasmosis. It is important to note that these outbreaks preceded the AIDS epidemic and the introduction of new biologicals such as tumor necrosis factor-α antagonists that are major risk factors for disseminated histoplasmosis. The reason for the devastating impact is not clear, but the risk factors that were identified included ages greater than 54 and immunosuppression. The scope of these two epidemics establish the importance of the urban setting, wind, and immune status when considering the impact of histoplasmosis on a population. Indianapolis did suffer another epidemic in the late ‘80s to the early ‘90s. However, this time, many of the cases developed in AIDS patients. This outbreak was not traced to a specific demolition or construction site. Rather, it might have been foci of H. capsulatum in the city and its neighborhoods that caused this increase in cases [22]. The major difference was that a highly susceptible population was now exposed, thus bringing the problem to medical attention earlier. A spelunker’s concern An often neglected but important source of Histoplasma outbreaks is a cave [23]. Bats have been associated with the development of histoplasmosis for many years, and seasoned spelunkers are aware of the risk. Bats harbor the fungus, and it has been isolated from their feces and other tissues. However, the caves do not necessarily have to be in the traditionally endemic regions since cave-associated histoplasmosis has been reported from Florida, South Africa, Tanzania, Cyprus, Australia, and Zimbabwe. Bats are not only found in caves but can be present in tunnels. A recent outbreak in the Dominican Republic highlighted this association [24]. A dam had five associated tunnels in which bats had been roosting, and a company was contracted to remove the guano, which reached up to one meter deep from the tunnels. Subsequently, all 36 workers became ill, and their illness was initially misdiagnosed. Of those exposed, >90% received antifungal therapy, indicating the severity of disease and likely the number of spores in the bat guano. The indoors and acquisition of histoplasmosis Not all the exposures to H. capsulatum require individuals to be in proximity to areas that are being excavated or where soil is disrupted. One outbreak occurred in a hotel in Acapulco, Mexico in which cleaning of air ducts and the use of stairwells was associated with the spread of spores that caused illness in 21 students who were vacationing over spring break [25]. Another outbreak was attributed to the dissemination of spores via the air handling system at the University of Texas Southwestern Medical School [26]. The likely source was a bird sanctuary near campus. The transmission was noted to be strictly indoors, and cases were more frequent in the upper floors. The air handling system was not constructed to remove small particles such as H. capsulatum spores. Other outbreaks related to air handling systems include one in which room air conditioners spread spores that had been swept off a roof of the building. Summary and conclusions Infection with H. capsulatum is not a reportable disease, and therefore, tracking the number of cases is a difficult task. Usually, histoplasmosis comes to our attention when there are outbreaks, whether they involve a few or a few thousand individuals. Once considered a rural disease of the Midwest and Southeast, the pattern of outbreaks has shifted to involve urban areas. Concomitantly, recognition of the disease as one of the Americas is simply no longer true. The geographic extent of the disease has broadened considerably, with an increasing number of reports from Asia. Occupational workers must be provided with the appropriate knowledge regarding the risks when they are tasked with environmental remediation for a site that potentially contains H. capsulatum spores. Unfortunately, no safe soil disinfectant is available that will kill spores; hence, the best protection for workers is the proper protective equipment and wetting of the soil to minimize aerosols.

          Related collections

          Most cited references22

          • Record: found
          • Abstract: found
          • Article: not found

          Epidemiology of Histoplasmosis Outbreaks, United States, 1938–2013

          Continued occurrence, particularly in work-related settings, highlights the need to increase awareness of this disease.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            HIV-Associated Histoplasmosis Early Mortality and Incidence Trends: From Neglect to Priority

            Introduction French Guiana is a French overseas territory, located in the North-Eastern part of South America. The Human Immunodeficiency Virus (HIV) epidemic there is the most preoccupying among French territories [1]. During the Highly Active AntiRetroviral Therapy (HAART) era, disseminated histoplasmosis has remained the most common Acquired Immunodeficiency Syndrome (AIDS) defining illness with an incidence of 15.4/1000 person-years in HIV-infected patients [2]. In immunocompetent patients, Histoplasma capsulatum var. capsulatum infection is typically asymptomatic or pauci-symptomatic and spontaneous resolution is the rule in the great majority of cases [3]. On the contrary, in HIV-infected patients it presents mostly as a disseminated infection. With the worsening of the immunosuppression, the disease progression is often rapid and always fatal in the absence of treatment [4]. Thus, different studies have observed up to 39% of deaths following diagnosis in endemic areas, where it is supposedly well known, and 58% in non endemic areas, where it is perhaps less known [5], [6]. In endemic areas, although there are different outcome measures and inclusion criteria, the death rates observed in AIDS-associated histoplasmosis differ between the USA (12–23%) and South America (19–39%) [6]. Hypotheses advanced to explain these differences are a delayed recognition due to the lack of awareness of physicians, a delayed diagnosis due to the lack of diagnostic facilities and the late presentation of HIV-infected patients in resource limited settings [6], [7], [8]. Delayed treatment due to the unavailability of the most effective therapy in severe cases, the impossibility of monitoring drug concentrations and/or drug-drug interactions with antituberculosis treatments are other possible explanations [6]. In French Guiana, disseminated histoplasmosis has also been the leading cause of death among HIV-infected patients [9]. Despite HIV care and treatment standards close to those in Mainland France, the mortality rate of AIDS-associated histoplasmosis remains high in the HAART era (30.7% at 6 months and 17.5 at 1 month), whereas in Mainland France, a non-endemic area, this mortality rate was divided by two [10], [11]. The objective of this study was to describe the temporal trends of incidence and mortality indicators for AIDS-associated histoplasmosis in French Guiana. This knowledge is important to guide and improve AIDS-associated histoplasmosis diagnosis, care and treatment, and to illustrate that awareness and standard practices in mycology can dramatically change prognosis. Materials and Methods Ethics Statement Since 1992, an anonymized database compiles retrospectively and continuously Histoplasma capsulatum var. capsulatum histoplasmosis confirmed incident cases diagnosed in HIV-infected patients according to the case definition of the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group [12]. The revised EORTC/MSG criteria defining a proven case of histoplasmosis are: recovery in culture from a specimen obtained from the affected site or from blood; and/or histopathologic or direct microscopic demonstration of appropriate morphologic forms with a truly distinctive appearance characteristic such as intracellular yeasts forms in a phagocyte in a peripheral blood smear or in tissue macrophages. By contrast, molecular methods of detecting fungi in clinical specimens, such as Polymerase Chain Reaction (PCR), were not included in the classifications of “proven,” “probable,” and “possible” invasive fungal disease (IFD) definitions because there is as yet no standard, and none of the techniques has been clinically validated. All HIV-infected patients hospitalized or seen in the outpatient department before admission, suspicious for histoplasmosis and receiving antifungal therapy in one of the three main hospitals of French Guiana (the Centre Hospitalier de Cayenne (CHC), the Centre Hospitalier Médico-Chirurgical de Kourou (CMCK) and the Centre Hospitalier de l'Ouest Guyanais in Saint Laurent du Maroni (CHOG), were identified and checked for a confirmed diagnosis of histoplasmosis in all laboratories where biological samples were sent. Then, they were finally enrolled according to the following inclusion criteria: age >18 years, admission in one of the three hospitals (the inclusion date corresponding to the date of antifungal treatment initiation), confirmed HIV infection (by Western blot), confirmed incident histoplasmosis infection (EORTC/MSG criteria), and baseline blood screening within 7 days prior to antifungal therapy initiation. Non inclusion criteria were: histoplasmosis relapse or diagnosis of histoplasmosis relying only on Histoplasma Polymerase Chain Reaction (PCR). Data were collected on a standardized form and included sociodemographic, clinical, biologic, radiologic, therapeutic and survival information. These data were then entered in an anonymized database. Ethical approval was obtained for the database and related studies (IRB0000388, FWA00005831). A descriptive study of the patients included in this database until April 2007 was published elsewhere [10]. Methods An observational, retrospective and multicentric study was conducted from 01/01/1992 to 09/30/2011, using the French Guiana HIV-Histoplasmosis database described above. In this study, the primary endpoint was the vital status on day 30 following antifungal therapy initiation. Patients lost to follow up within 30 days following antifungal therapy initiation, or deceased with an unknown date of death, or presenting a relapse of histoplasmosis were excluded from the analysis. This early death criterion appeared as a good compromise to attribute mortality to the histoplasmosis infectious episode under consideration, in a context of severe immunosuppression favouring multiple opportunistic pathogens, ensuring simplicity and reproducibility of the study. The statistical analysis was performed using STATA 10.0 (College Station, Texas, USA) (38). Descriptive analysis used proportions, medians and trend χ2 test. Results There were 278 patients with AIDS-associated histoplasmosis. Four cases were excluded before the analysis (3 because they were lost to follow up and one because of an unknown date of death). Their socio-demographic characteristics and median CD4 count did not differ from the 274 patients finally selected in this study (data not shown). Among the 274 patients selected for whom the vital status at 30 days after antifungal therapy initiation was known, there were 124 deaths (45.3%). The median time to death was 110 days (Interquartile Range [IQR] = 13–481) and the median age at the time of death was 39 years (IQR = 33–47). Early death occurred in 46 patients (16.8%) with a median survival time of 7 days (IQR = 3–16) after antifungal treatment initiation. The median age at the time of early death was 37 years (IQR = 32–47). Figure 1 shows that the proportion of deaths occurring the same year as the diagnosis of incident histoplasmosis cases remained stable around 5 deaths per year until 2005/2006 and then stabilized around 3 deaths per year. Among these deaths cases, almost half were early deaths until 2004. From 2005 onwards there was a notable decline of early deaths along with the overall decline of mortality. In addition, starting in 1998, the number of histoplasmosis cases diagnoses increased, and subsequently the number of incident cases oscillated between 14 and 22 cases per year. Data were incomplete for 2011, the study considering cases only until 09/30/2011. 10.1371/journal.pntd.0003100.g001 Figure 1 Number of deaths and early deaths observed among annual incident histoplasmosis cases diagnosed in the three main hospitals of French Guiana between 01/01/1992 and 09/30/2011. Thus, three time periods of particular interest have been identified: 1992–1997, 1998–2004 and 2005–2011. Figure 2 summarizes the two main temporal trends observed in Figure 1. First, the proportion of early deaths among annual incident histoplasmosis cases was significantly divided four fold (χ2, p 1% since the 1990's: 0.8%–1.4% between 1992–1997, 1.2%–1.4% between 1998–2004 and 1.0%–1.2% between 2005–2011 [1], [13]. The increased number of annual histoplasmosis cases can be attributed to the development of medical mycology skills in hospitals laboratories, notably a reference university laboratory specialized in parasitology-mycology established since 1997 in Cayenne Hospital. By the same time, highly active antiretroviral therapy was introduced, which could have led to more patent cases of histoplasmosis due to the immune reconstitution inflammatory syndrome [14]. In addition, a PCR diagnostic method became available for histoplasmosis in 2006 [15]. Unfortunately, urinary antigen detection for histoplasmosis is still unavailable in French Guiana. The sharp decline of the proportion of early deaths can be attributed to the improvement of the diagnostic capacity along with the improvement of the clinical management of HIV-infected patients following French recommendations [16]. Thus, French Guiana reached HIV-virological suppression levels comparable to those in Mainland France by 2004. In addition, this trend can also be attributed to the improvement of the clinical management of AIDS-related disseminated histoplasmosis cases. The accurate recognition of severe cases and the supply of liposomal amphotericin B since 1998, an effective and less nephrotoxic treatment recommended for severe disseminated histoplasmosis cases, were two important factors behind the progress. This study had limitations. Data were collected retrospectively, which might have led to selection biases. Determining retrospectively if death was related to AIDS-associated histoplasmosis incident cases under study is challenging, considering the high percentage of concomitant opportunistic infections. Thus, we chose early death as the primary outcome because we thought that retrospectively it was the simplest and most reproducible indicator of histoplasmosis AIDS-related deaths. Despite its limitations, this study showed that capacity building both in laboratory and clinical practice, effective drug availability both for HIV and histoplasmosis infections, and an effective bench to bed collaboration between actors progressively helped in reducing the burden of overall deaths and early deaths. Mortality indicators are now consistent with those described in North America, where the most effective and non invasive histoplasmosis diagnostic method is available. To further reduce early mortality, reducing diagnostic delays and antifungal therapy initiation is still a major objective. To reach it, a diagnostic method that meets the World Healh Organization's A.S.S.U.R.E.D. (Affordable, Sensitive, Specific, User-friendly, Rapid/Robust, Equipment-free and Delivered) should be developed. Although our results may seem parochial, they illustrate the rapid progress that took place within a decade. The increased awareness of clinicians, who became more aggressive in their investigations, and the increased laboratory capacity led to find and treat a disease that was present but probably not identified and not treated in time. Thus, histoplasmosis, previously known as a mild disease in immunocompetent individuals, became a public health problem in HIV-infected patients, known by almost all health practitioners in French Guiana. By dealing with the mycology diagnostic tool box limitations and starting prompt presumptive antifungal treatment in HIV-infected patients it was possible to reduce early deaths considerably. The historical 40% of early deaths observed in French Guiana, where histoplasmosis was known, plausibly reflects a low estimate of what happens in the Amazon region and probably beyond, where histoplasmosis is endemic but probably still widely misdiagnosed for tuberculosis and/or neglected [17]. Although cost effective strategies to prevent the disease and very effective diagnostic methods have been developed and are well known by scattered medical teams in Latin America [18], this knowledge does not percolate to too many HIV care units and hospital laboratories [19]. The present example testifies that rapid progress could be at reach if awareness increased and led to implement clinical and laboratory capacity building in order to diagnose and treat this curable disease before it is too late.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Histoplasma capsulatum: More Widespread than Previously Thought

              Histoplasmosis is an endemic mycosis caused by a dimorphic fungus with two distinct varieties pathogenic for humans: Histoplasma capsulatum var. capsulatum and H. capsulatum var. duboisii. The latter is known to be restricted to sub-Saharan Africa, whereas the former is distributed worldwide. However, general textbooks of medical mycology when considering the geographic distribution of H. capsulatum var. capsulatum either refer only to “eastern United States (Ohio, Mississippi, and St. Lawrence River valleys) and most of Latin America,”1 or indicate that “isolated cases have been reported also from Southeast Asia and Africa.”2 In this issue of the Journal, Wang and others3 describe an autochthonous case of disseminated progressive histoplasmosis (DPH) observed in a young human immunodeficiency virus (HIV)-negative Chinese man. This report adds to the growing evidence from epidemiological surveys using histoplasmin skin tests,4 case reports,5 and a recent review of the literature6 (mostly of works written in Chinese) indicating that some areas of China should be included among those with medium-high endemicity for H. capsulatum. However, because China is one of the largest countries in the world, epidemiological information for clinicians should take into account which specific areas are involved. In this regard the histoplasmin skin test survey conducted by Zhao and others,4 showed an overall reactivity of 9.0% among 735 healthy volunteers and patients with lung diseases, with the highest prevalence observed in Hunan (8.9%) and Jiangsu (15.1%) provinces. In good agreement, in a review of 300 cases of histoplasmosis diagnosed in China (75% considered autochthonous),6 the geographical distribution of patients was 27.7% from Yunnan, 9.3% from Jiangsu and Hunan, 8.7% from Hubei and 7.3% from Sichuan. Another histoplasmin skin test survey conducted on 271 healthy students from Sichuan province showed a prevalence ranging from 6% to 35%, with the highest recorded in the southern part of the province.7 Overall, nearly 82% of all reviewed cases of histoplasmosis from China were reported from nine provinces through which the Yangtze River flows and where climate conditions are probably favorable for H. capsulatum growth6; it is worth noting that 86% of these cases were classified as disseminated, and in 52% of affected patients no underlying diseases were disclosed. India is another Asian country where H. capsulatum is known to be endemic, although the true prevalence of this mycosis is still underappreciated. The first case was reported as early as 1954, and since then several cases (mostly DPH, even in the absence of underlying immunosuppression) have been published.8–10 In India the majority of histoplasmosis cases were reported from the eastern and north-eastern part of the country, especially from Calcutta (West Bengal) and Assam. Interestingly, as observed for the highly endemic areas in North America, both states are crossed by long rivers: the Ganges and the Brahamaputra, respectively.8–10 Moreover, the fungus was isolated from the soil of the Gangetic plains.11 A histoplasmin skin-test positivity rate of 12.3% was reported in northern India between the 1950s and 1970s.12 It has been hypothesized that in India a large number of cases might be unrecognized for a long period caused by low awareness of the disease and misdiagnose as tuberculosis or leishmaniasis.8,10 Oral cavity ulcers and bilateral adrenal enlargement seem to be particularly frequent among Indian patients, whereas skin lesions were observed in only 8% of cases.8,10 Also in the review of Chinese patients skin involvement was reported in a small fraction of cases (6.6%) and the authors speculated about the low number of HIV-positive patients in their file records.6 High rates of skin involvement have been observed among HIV-positive patients from South America and Africa.13 Thailand is another country of South-east Asia where localized foci of H. capsulatum exist, and the fungus has been shown by using nested polymerase chain reaction of soil contamined with bat guano and chicken droppings from Chiang Mai, a geographic area where Penicillium marneffei is also endemic.14 In contrast to the Chinese and Indian experiences, DPH in Thailand has been observed almost exclusively among HIV-infected patients, with 1,253 cases reported from 1984 to 2010 to the Ministry of Public Health.14 Based on sporadic case reports of autochthonous histoplasmosis, isolation of the fungus from soil in bat-infested caves and histoplasmin skin test surveys, Malaysia, Indonesia, Myanmar, and the Philippines should also be considered areas with pockets of endemicity for histoplasmosis.15,16 Interestingly, in a recent survey conducted in Europe, cases of disseminated histoplasmosis were diagnosed among elderly United Kingdom residents who had served in World War II in India and Myanmar and who did not leave their country of origin for more than 50 years after returning home.17 In Australia, cases of indigenous histoplasmosis were reported as early as 1948, and the organism has been cultured from fowl yards and caves, although the exact ecology is poorly understood18; the majority of cases were reported from the Queensland and northern New South Wales regions, which are characterized by tropical and subtropical climate. These regions are also crossed by long rivers (the Dumaresq and Macintyre rivers). Outside Asia autochthonous cases of histoplasmosis have been reported sporadically from Italy,13,17 where studies conducted in the 1960s confirmed the presence of H. capsulatum in soil19 and animals,20 with the existence (confirmed with histoplasmin skin tests) of a pocket of endemicity along the Po River valley.21 Histoplasma capsulatum var. duboisii, characterized by a larger size (8–15 μm) and thicker walls than H. capsulatum var. capsulatum, is found in Madagascar and in central and western regions of sub-Saharan Africa (Malì, Chad, Niger, Nigeria, Democratic Republic of Congo, and Ghana). It is classically associated with skin, subcutaneous, and bone lesions, but disseminated disease has been described among HIV-positive patients22; because both pathogens coexist in Africa,13,17 it has been suggested that until the correct variety of the fungus has been identified African patients should not be described as affected by “African histoplasmosis.”17 In conclusion, our knowledge of the true worldwide distribution of H. capsulatum is still incomplete, and works such as that of Wang and coworkers are worthwhile. Improved access to diagnostic tests and increased awareness of the disease outside the well-known endemic areas will be helpful in redrawing the map of the geographic extent of this infection. Moreover, in an era of increasingly mobile people, physicians need to consider histoplasmosis in travelers and immigrants from the Indian subcontinent and South-east Asia in addition to regions traditionally considered endemic.
                Bookmark

                Author and article information

                Contributors
                Role: Editor
                Journal
                PLoS Pathog
                PLoS Pathog
                plos
                plospath
                PLoS Pathogens
                Public Library of Science (San Francisco, CA USA )
                1553-7366
                1553-7374
                13 September 2018
                September 2018
                : 14
                : 9
                : e1007213
                Affiliations
                [001]Division of Infectious Diseases, Department of Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio
                McGill University, CANADA
                Author notes

                The author has declared that no competing interests exist.

                Author information
                http://orcid.org/0000-0001-6158-6461
                Article
                PPATHOGENS-D-18-01156
                10.1371/journal.ppat.1007213
                6136805
                30212569
                a5df0d68-2a71-47d9-98a7-a0f8c0c5580c
                © 2018 George S. Deepe

                This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

                History
                Page count
                Figures: 0, Tables: 0, Pages: 5
                Funding
                This work was supported by funds from the National Institutes of Health ( https://www.niaid.gov) grants R01 AI 106269 (GSD), AI 133797 (GSD), and AI 126818 (GSD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
                Categories
                Pearls
                Biology and Life Sciences
                Microbiology
                Medical Microbiology
                Microbial Pathogens
                Fungal Pathogens
                Histoplasma Capsulatum
                Medicine and Health Sciences
                Pathology and Laboratory Medicine
                Pathogens
                Microbial Pathogens
                Fungal Pathogens
                Histoplasma Capsulatum
                Biology and Life Sciences
                Mycology
                Fungal Pathogens
                Histoplasma Capsulatum
                Medicine and Health Sciences
                Infectious Diseases
                Fungal Diseases
                Histoplasmosis
                Biology and Life Sciences
                Organisms
                Eukaryota
                Fungi
                Medicine and Health Sciences
                Epidemiology
                Biology and Life Sciences
                Organisms
                Eukaryota
                Animals
                Vertebrates
                Amniotes
                Birds
                Biology and Life Sciences
                Organisms
                Eukaryota
                Animals
                Vertebrates
                Amniotes
                Mammals
                Bats
                Biology and Life Sciences
                Mycology
                Fungal Reproduction
                Fungal Spores
                Biology and Life Sciences
                Organisms
                Eukaryota
                Fungi
                Molds (Fungi)

                Infectious disease & Microbiology
                Infectious disease & Microbiology

                Comments

                Comment on this article